Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
US Army
Cipla
Johnson and Johnson
Colorcon
Queensland Health
UBS
McKesson
McKinsey

Generated: June 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020713

« Back to Dashboard

NDA 020713 describes MIRCETTE, which is a drug marketed by Teva Branded Pharm and is included in one NDA. Additional details are available on the MIRCETTE profile page.

The generic ingredient in MIRCETTE is desogestrel; ethinyl estradiol. There are eight drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.
Summary for 020713
Tradename:MIRCETTE
Applicant:Teva Branded Pharm
Ingredient:desogestrel; ethinyl estradiol
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORAL-28Strength0.15MG,N/A;0.02MG,0.01MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Apr 22, 1998TE:RLD:Yes

Expired US Patents for NDA 020713

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Branded Pharm MIRCETTE desogestrel; ethinyl estradiol TABLET;ORAL-28 020713-001 Apr 22, 1998 ➤ Sign Up ➤ Sign Up
Teva Branded Pharm MIRCETTE desogestrel; ethinyl estradiol TABLET;ORAL-28 020713-001 Apr 22, 1998 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Fuji
Healthtrust
Teva
Covington
QuintilesIMS
Boehringer Ingelheim
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.